Chicago, IL, United States of America

Natalie J Fuller

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignees: Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Natalie J Fuller

Introduction

Natalie J Fuller is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of regenerative medicine. With a focus on enhancing tissue regeneration, her work has the potential to impact various medical applications.

Latest Patents

One of her notable patents is titled "Isolation and co-transplantation of bone marrow mesenchymal stem cells with CD34+ hematopoietic stem/progenitor cells." This patent outlines methods for isolating and co-administering populations of bone marrow mesenchymal stem cells (MSCs) and CD34+ hematopoietic stem/progenitor cells (HSPCs). The methods provided aim to enhance tissue regeneration, particularly in the bladder.

Career Highlights

Throughout her career, Natalie has worked with esteemed institutions such as Northwestern University and Ann & Robert H. Lurie Children's Hospital of Chicago. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Arun K Sharma and Matthew I Bury, who have also made significant contributions to the field of regenerative medicine.

Conclusion

Natalie J Fuller is an influential inventor whose work in regenerative medicine continues to pave the way for advancements in tissue regeneration. Her innovative approaches and collaborations highlight her commitment to improving medical outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…